Growing Revenue, TWST Set to Launch?Digital Health & Medical AI is on the rise ...and so is TWST's Revenue.
It is tipped that artificial intelligence will play a key role in the development of industry wide efficiencies, with many advancements occurring over the last 12 months within the Medical Technologies space.
One key player could be TWIST Bioscience Corporation NASDAQ:TWST , who have developed a synthetic DNA manufacturing process.
Momentum Guide - Rating has now been upgraded to 'Bullish'.
Here's our price guide:
Bullish Continuation Potential above $48.71
Bearish Continuation Risk below $39.93
We're inspired to bring you the latest developments across worldwide markets, helping you look in the right place, at the right time - We will continue to monitor the Digital Health space in the event there are any rapid changes.
Thank you for reading! Stay tuned for further updates, and we look forward to being of service along your trading & investing journey...
Please note all information contained within this post is strictly for informational purposes only and is not intended to be investment advice. Please DYOR & Consult your licensed financial advisors before acting on any information contained within this post.
Love & Wisdom,
TWST trade ideas
Long-term bottoms for Position Trade OpportunitiesNASDAQ:TWST reports tomorrow and has been trending up but doesn't have a pre earnings run. However, the stock has completed a long term bottom which provides strong support. Position trade candidate after the earnings volatility settles out. Institutional Holdings are very high.
Twist Biosciences (TWST) AnalysisInnovation and Market Leadership:
Twist Biosciences NASDAQ:TWST , a leader in synthetic DNA products, is set for substantial growth with its new Express Genes service, offering NGS-verified genes in just five to seven business days. This innovation is expected to strengthen Twist's market position and dominance.
Growth Forecast and Market Expansion:
The company forecasts a CAGR of over 28% through 2025, backed by a customer base of over 3,300 across various industries. Targeting multiple large addressable markets, Twist aims to sustain revenue growth for the foreseeable future.
Investment Outlook:
Bullish Outlook: We are bullish on TWST above the $41.00-$42.00 range.
Upside Potential: With an upside target set at $76.00-$78.00, investors should consider Twist's innovative service offerings and robust growth projections as key drivers for potential stock appreciation.
📊🧬 Monitor Twist Biosciences for promising investment opportunities! #TWST #SyntheticDNA 📈🔍
Swing Trading Setups: TWSTThis is a stock that went on my students' watchlists this week for potential swing trading.
NASDAQ:TWST is coming out of a long-term down-trending correction and has completed the bottom. Accumulation ended and a HFT gap and run up followed on May 3rd. The stock retested the sideways trend highs which are now support for the current price.
Pro traders are swing trading in these patterns. There are fewer wicks and tails and the stock has a very high Percentage of Shares Held by Institutions.
Strategic Insights and Future Aspirations: My Investment JourneyNASDAQ:TWST I researched TWST stock about a year and a half ago, around the beginning of 2023. It was noticeable that there was also a gap that initiated a downward trend, and I waited for the stop squeeze around the $10-12 price range. Unfortunately, due to liquidity issues at that time, I was unable to catch it at the $13 entry price I desired and entered in June at a price of $17.22 per share. Since then, the stock has risen and corrected slightly downwards, but I am aiming for a price of about $100 per share. At the moment, I feel I'm on the right track, and if I sense any change in trend or fundamental shift, I will consider a strategic change.
This is not advice or a recommendation. NASDAQ:TWST
Twist Bioscience - Better Than Expected Both earnings and revenue are better than expected! The reaction is still muted but on the chart we have a beautiful descending triangle with a breakout starting. We could very well back test as we are a bit overbought, we could also just go sideways or up. I have already established an entry but I think anywhere in the 12-13 range will be rewarded later this year if not sooner. Not financial advice, DYOR.
Let's do the TWST again - Buy under 29I like the potential of this stock to run up to $42. I'll likely be reanalyzing my sell point often if the stock were to pump upwards after hitting somewhere under 28.18.
I think at some point late in the week, we'll see the dip, and I'll be looking to buy if we can hold support and form a new trend.
TWST - mini double bottomAfter a spectacular fall (of 88%) all the way back to covid pandemic low, TWST appear to have found bottom @ abt $25 on 12th May and then retested this level again on 13 June. There were some signs of high volume accumulation on days following these low.
The 21day moving average has recently crossed above the 50 day moving average and RSI is now showing strength (>60). It is likely that the worst is over for TWST. Any near term pullback towards the neckline around 38 will be an opportunity to long.
Disclaimer: Just my 2 cents and not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance and don't forget that money management is important! Take care and Good Luck!
A purely technical view on TWSTCurrently down 70% from ATH, TWST may be a good buy at these levels. Idk anything about the technology or revenue streams but Jakey mac likes the stock so i charted it out for him. $46-48/share appears as strong support with $66 being sturdy resistance. If 46 breaks, then 40 and 36 are also significant support zones. Could see breakout if we hold above 66, but until then you have some time to DCA into a position.
$TWSTEntry price : 138.03
Fundamentals :
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 44%
- EPS % Chg (Previous Qtr): 27%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 106%
- Sales % Chg (Previous Qtr): 56%
- 3-Year Sales Growth Rate: 101%
- Annual Pre -Tax Margin: -129.9%
TWST - Uptrend looks like it'll continueAbove MA's, respecting trend, still a bullish chart.
Twist has essentially invented a new way to “print” DNA onto a microchip so it can be tweaked, analyzed, and researched. This groundbreaking technology makes it possible to reconfigure DNA into something entirely new.
DNA is, of course, the code of life. It’s what makes us who we are. By rearranging DNA, weccan create new organisms with more characteristics that we like, while removing the ones we dislike.
Twist’s DNA synthesis platform is already being used to develop COVID treatments, as well as the anti-malaria drug artemisinin. In short, Twist is helping to lay the foundation for a biotech revolution… much like Intel did with the American computer revolution.
But Twist is much, much more than a biotechnology play. Its technology is also being used to develop new chemicals for industrial processes, new food flavors, novel materials like spider silk, and even plants that are self-fertilizing and drought tolerant.
Its silicon-based chip technology can increase DNA production by 9,600X over traditional DNA synthesis methods. This is possible thanks to one of Twist’s core proprietary
technologies that can manufacture synthetic DNA by “writing” it on a silicon chip.
TWST, RSI Indicator left the overbought zone on January 21, 2021This is a signal that TWST's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked back and found 24 similar cases where TWST's RSI Indicator left the overbought zone, and in 20 of them led to a successful outcome. Odds of Success: 83%. Current price $191.80 is above $104.05 the highest support line found by Tickeron A.I. Throughout the month of 12/17/20 - 01/21/21, the price experienced a +35% Uptrend. During the week of 01/13/21 - 01/21/21, the stock enjoyed a +16% Uptrend growth.
Bearish Trend Analysis
The 10-day RSI Indicator for TWST moved out of overbought territory on January 21, 2021. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Indicator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TWST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.